Oxford Performance Materials to Expand into Asia

Oxford Performance Materials (OPM), provider of materials for high performance additive manufacturing (HPAM™), announced a partnership with Tokyo-based JSR Corporation (JSR) to advance OPM’s PEKK-based 3D-printed orthopaedic devices and biomedical and dental materials businesses throughout Asia.

JSR is a materials supplier in a variety of technology-driven markets.

Under agreement terms, OPM and JSR will establish operations in Japan as OPM Asia, with an exclusive regional license to distribute OPM’s OsteoFab® biomedical device 3D-printing technology and OXPEKK® materials technology. JSR will provide equity capital. The OPM Asia license will cover a broad territory comprising Brunei Darussalam, Cambodia, China, India, Japan, Korea, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Taiwan, Thailand, and Vietnam.

OPM Asia is scheduled to establish its Japanese manufacturing facility later this year, with products commercially available to the Asian market in 2Q19.

“Asia’s healthcare industry is growing rapidly, and with that growth comes increased demand for medical innovation that delivers improved clinical effectiveness to more people with superior economics,” said Scott DeFelice, Chief Executive Officer of OPM. “The healthcare industry in Asia is expected to grow by 11.1% to $517 billion in 2018, representing one of the fastest-growing regions in the world. OPM has long identified Asia as an attractive market due to clear demographic trends and a predictable regulatory and reimbursement environment.”

DeFelice will serve as the CEO of OPM Asia and serve on its Board of Directors. Joining Mr. DeFelice on the founding board will be Bernard Plishtin from OPM and one member from JSR.

In March, OPM was granted Accreditation of Foreign Medical Device Manufacturer by the Japanese Ministry of Health, Labour and Welfare.

Source: OPM

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE